Bayer (BAYRY)
(Delayed Data from OTC)
$7.54 USD
+0.06 (0.76%)
Updated May 24, 2024 03:59 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Price, Consensus and EPS Surprise
BAYRY 7.54 +0.06(0.76%)
Will BAYRY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BAYRY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BAYRY
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
BAYRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Other News for BAYRY
Harris Associates Global Strategy Q1 2024 Commentary
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Dodge & Cox International Stock Fund Q1 2024 Shareholder Letter
Harris Associates Global All Cap Strategy Q1 2024 Commentary
Harris Associates International Equity Strategy Q1 2024 Commentary